Digene gets U.S. approval for HPV test

FDA approved DIGE's High-Risk Hybrid Capture II HPV test, a DNA-based diagnostic to detect the 13 main strains of human papillomavirus, which causes cervical cancer. DIGE was down $0.25 to $49.75 on T...